Document is current

Any future updates will be listed below

Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM

Crossref DOI link: https://doi.org/10.1038/s41598-025-96996-3

Published Online: 2025-04-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark